Several studies in January have shown Paxlovid's inability to prevent Long COVID and a new study published in the New England Journal of Medicine on April 3, 2024, casts further doubt on Paxlovid's efficacy.T.A.C.T. is a reader-supported publication. To receive new posts and support this work, consider becoming a free or paid subscriber.
...and the remarkable thing is, this study was funded by Pfizer acknowledging their drug doesn't work.
Reminds me of that meme with the two astronauts floating in space.
Astronaut 1: "You mean Paxlovid doesn't work?"
Astronaut 2: "Never did."
Now, on to something completely different if you haven't seen it.
The reference linked below is written in a very odd way.
The TITLE seems to promote transitioning to annual SARS-CoV-2 vaccination, but the rest of the abstract doesn't appear to address the pros/cons of yearly vaccination, but rather best practices in dosing regimens.
...and the remarkable thing is, this study was funded by Pfizer acknowledging their drug doesn't work.
Reminds me of that meme with the two astronauts floating in space.
Astronaut 1: "You mean Paxlovid doesn't work?"
Astronaut 2: "Never did."
Now, on to something completely different if you haven't seen it.
The reference linked below is written in a very odd way.
The TITLE seems to promote transitioning to annual SARS-CoV-2 vaccination, but the rest of the abstract doesn't appear to address the pros/cons of yearly vaccination, but rather best practices in dosing regimens.
Anyway, thought you might find it of interest...
https://www.acpjournals.org/doi/10.7326/M23-2451